Evidence map›Paper›PMID 42075797›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Identification of Dopamine D2 Receptor as a Direct Target of Salidroside and Tyrosol by Integrated Transcriptomic and Biophysical Approaches.

Jizhou Zhang, Kan Lin, Chang Jiang, Jiabing Zheng, Huihui Huang, Jing Han

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jizhou ZhangInstitute of Materia Medica, Fujian Academy of Chinese Medical Science, Fuzhou 350003, China.
Kan LinFujian Medical University Union Hospital, Fuzhou 350001, China.ORCID 0000-0001-8855-2173
Chang JiangInstitute of Materia Medica, Fujian Academy of Chinese Medical Science, Fuzhou 350003, China.
Jiabing ZhengFujian Medical University Union Hospital, Fuzhou 350001, China.
Huihui HuangFujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou 350108, China.
Jing HanInstitute of Materia Medica, Fujian Academy of Chinese Medical Science, Fuzhou 350003, China.ORCID 0000-0002-7142-1991

Funding

Joint Funds for the innovation of Science and Technology,Fujian province 2025Y9274Natural Science Foundation of Fujian Province of China 2021J01910Natural Science Foundation of Fujian Province of China 2023J01313Open Project Fund of Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research FKLDSR-202301
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Connectivity Map databasedopamine D2 receptorERKsalidrosidetyrosol

Identifiers

PMID42075797
PMCPMC13119093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.